Matches in SemOpenAlex for { <https://semopenalex.org/work/W3183995777> ?p ?o ?g. }
- W3183995777 endingPage "1414" @default.
- W3183995777 startingPage "1403" @default.
- W3183995777 abstract "Introduction: In the COVID-19 pandemic emergency, research has been oriented toward the development of therapies that could cure critically ill patients and treatments that can reduce the number of hospitalized patients, in order to ease the pressure on health-care systems. Bamlanivimab, developed from human convalescent plasma, was the first monoclonal antibody to become available for emergency use in several countries. Expectations related to its use in COVID-19 patients as a single agent have been largely disregarded, especially against E484K-carrying SARS-CoV-2 variants.Areas covered: In this drug discovery case history, the development of the drug is described starting from the identification and selection of the antibody, from the pre-clinical and clinical trials up to the post-authorization phase.Expert opinion: Bamlanivimab has shown some efficacy in patients with mild to moderate COVID-19. Initially approved as a monotherapy, due to poor efficacy it is currently only usable in combination with etesevimab. Pharmacokinetic limitations and mainly the onset of SARS-CoV-2 variants are the main reasons for this limited clinical use. The use in preventing hospitalization also has ethical limits related to the sustainability of care, especially if, considering similar effectiveness, bamlanivimab is compared with convalescent plasma." @default.
- W3183995777 created "2021-08-02" @default.
- W3183995777 creator A5005487649 @default.
- W3183995777 creator A5008924698 @default.
- W3183995777 creator A5011221484 @default.
- W3183995777 creator A5039914248 @default.
- W3183995777 creator A5058374861 @default.
- W3183995777 creator A5089203948 @default.
- W3183995777 creator A5089273110 @default.
- W3183995777 date "2021-07-30" @default.
- W3183995777 modified "2023-10-18" @default.
- W3183995777 title "An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future" @default.
- W3183995777 cites W1968924668 @default.
- W3183995777 cites W2113236498 @default.
- W3183995777 cites W2156826143 @default.
- W3183995777 cites W2200798239 @default.
- W3183995777 cites W2295174527 @default.
- W3183995777 cites W2808892459 @default.
- W3183995777 cites W2933635354 @default.
- W3183995777 cites W2969525890 @default.
- W3183995777 cites W3009335299 @default.
- W3183995777 cites W3027630905 @default.
- W3183995777 cites W3034889157 @default.
- W3183995777 cites W3087347658 @default.
- W3183995777 cites W3087924281 @default.
- W3183995777 cites W3096658347 @default.
- W3183995777 cites W3112311859 @default.
- W3183995777 cites W3115009914 @default.
- W3183995777 cites W3125712166 @default.
- W3183995777 cites W3126795127 @default.
- W3183995777 cites W3132891189 @default.
- W3183995777 cites W3136103455 @default.
- W3183995777 cites W3137411890 @default.
- W3183995777 cites W3138251214 @default.
- W3183995777 cites W3139897394 @default.
- W3183995777 cites W3144086685 @default.
- W3183995777 cites W3149428818 @default.
- W3183995777 cites W3153834471 @default.
- W3183995777 cites W3155123963 @default.
- W3183995777 cites W3155179846 @default.
- W3183995777 cites W3164832774 @default.
- W3183995777 cites W3165379786 @default.
- W3183995777 cites W3177020296 @default.
- W3183995777 cites W3178509854 @default.
- W3183995777 cites W3180923996 @default.
- W3183995777 doi "https://doi.org/10.1080/17460441.2021.1960819" @default.
- W3183995777 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8353660" @default.
- W3183995777 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34304682" @default.
- W3183995777 hasPublicationYear "2021" @default.
- W3183995777 type Work @default.
- W3183995777 sameAs 3183995777 @default.
- W3183995777 citedByCount "16" @default.
- W3183995777 countsByYear W31839957772021 @default.
- W3183995777 countsByYear W31839957772022 @default.
- W3183995777 countsByYear W31839957772023 @default.
- W3183995777 crossrefType "journal-article" @default.
- W3183995777 hasAuthorship W3183995777A5005487649 @default.
- W3183995777 hasAuthorship W3183995777A5008924698 @default.
- W3183995777 hasAuthorship W3183995777A5011221484 @default.
- W3183995777 hasAuthorship W3183995777A5039914248 @default.
- W3183995777 hasAuthorship W3183995777A5058374861 @default.
- W3183995777 hasAuthorship W3183995777A5089203948 @default.
- W3183995777 hasAuthorship W3183995777A5089273110 @default.
- W3183995777 hasBestOaLocation W31839957772 @default.
- W3183995777 hasConcept C108759981 @default.
- W3183995777 hasConcept C126322002 @default.
- W3183995777 hasConcept C177713679 @default.
- W3183995777 hasConcept C2779134260 @default.
- W3183995777 hasConcept C2780035454 @default.
- W3183995777 hasConcept C2910824759 @default.
- W3183995777 hasConcept C3007834351 @default.
- W3183995777 hasConcept C3008058167 @default.
- W3183995777 hasConcept C38652104 @default.
- W3183995777 hasConcept C41008148 @default.
- W3183995777 hasConcept C524204448 @default.
- W3183995777 hasConcept C535046627 @default.
- W3183995777 hasConcept C64903051 @default.
- W3183995777 hasConcept C71924100 @default.
- W3183995777 hasConcept C89623803 @default.
- W3183995777 hasConcept C98274493 @default.
- W3183995777 hasConceptScore W3183995777C108759981 @default.
- W3183995777 hasConceptScore W3183995777C126322002 @default.
- W3183995777 hasConceptScore W3183995777C177713679 @default.
- W3183995777 hasConceptScore W3183995777C2779134260 @default.
- W3183995777 hasConceptScore W3183995777C2780035454 @default.
- W3183995777 hasConceptScore W3183995777C2910824759 @default.
- W3183995777 hasConceptScore W3183995777C3007834351 @default.
- W3183995777 hasConceptScore W3183995777C3008058167 @default.
- W3183995777 hasConceptScore W3183995777C38652104 @default.
- W3183995777 hasConceptScore W3183995777C41008148 @default.
- W3183995777 hasConceptScore W3183995777C524204448 @default.
- W3183995777 hasConceptScore W3183995777C535046627 @default.
- W3183995777 hasConceptScore W3183995777C64903051 @default.
- W3183995777 hasConceptScore W3183995777C71924100 @default.
- W3183995777 hasConceptScore W3183995777C89623803 @default.
- W3183995777 hasConceptScore W3183995777C98274493 @default.
- W3183995777 hasIssue "12" @default.
- W3183995777 hasLocation W31839957771 @default.